Rapid Neurological Decline due to Creutzfeldt-Jakob Disease

Area of Science:

• Neurology
• Rare Diseases

Background:

• Creutzfeldt-Jakob Disease (CJD) is an extremely rare neurodegenerative disorder.
• Global incidence is approximately one case per million individuals annually.

Purpose of the Study:

• To outline the diagnostic criteria for Creutzfeldt-Jakob Disease.
• To emphasize the importance of timely diagnosis in managing patient care and prognosis.

Main Methods:

• Diagnosis relies on identifying rapid neurological decline.
• Cerebrospinal fluid (CSF) biomarkers are utilized.
• Neuroimaging, including Magnetic Resonance Imaging (MRI) and Electroencephalography (EEG), provides key diagnostic findings.

Main Results:

• Diagnostic findings include characteristic symptoms and specific biomarker results.
• MRI and EEG show distinct patterns indicative of CJD.
• No effective therapies are currently available for CJD.

Conclusions:

• Prompt diagnosis of CJD is essential for effective patient management.
• Early identification facilitates discussions regarding disease prognosis and goals of care.
• Further research into CJD therapies remains a critical unmet need.